βPursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors of the Company has passed the necessary resolution through Circular Resolution, on Tuesday, December 17, 2024 and has fixed the record date on Wednesday, January 8, 2025 for the purpose of Sub-division/Split of equity shares of the Company such that 1 (one) equity share having face value of Rs. 5/- (Rupees five only) each, fully paid-up, be sub-divided into such number of equity shares having face value of Rs. 2 (Rupee two only) each,β the company had said in a previous exchange filing.
Shareholders who buy the stock at least one day before the ex-date are eligible for the offers as settlement happens the next day. Those buying the stock on the ex-date are not eligible for dividends/splits/bonus issues etc.
After the implementation of the T+1 framework, the ex-date and record date usually fall on the same day (except if there is a stock market holiday on the record date).
Jagsonpal Pharmaceuticals share price history
Shares of Jagsonpal Pharmaceuticals have increased by 55.8% in the last one year and by 86.9% in the last 6 months, according to the BSE analytics. However, in the short term, the stock has tumbled by nearly 10% (1 month).
Other stocks to trade ex-split on January 8
AA Plus Tradelink had announced a stock split from Rs 10 to Rs 1.
Julien Agro Infratech had announced a stock split from Rs 10 to Rs 5.
Kamdhenu Ltd had announced a stock split from Rs 10 to Rs 1.
Also read: FPIs heavily bearish, but that may well be a bullish signal
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Source link
